Evidence map›Paper›PMID 42485607›Full record

ArticleNeurology2026

Associations of Alzheimer Disease and Related Dementia Neuropathologies With Timely Diagnosis of Dementia in Healthcare Settings.

Yi Chen, Annie Chen, Melinda C Power, Francine Grodstein, Alifiya Kapasi, Ana W Capuano, Brittney S Lange-Maia, Ali Moghtaderi, Emma K Stapp, Joya Bhattacharyya and 4 more

Abstract read
In one paragraph

Article in Neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Yi ChenRush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL.ORCID 0009-0005-1045-0501
Annie ChenDepartment of Epidemiology, Milken Institute School of Public Health, George Washington University, Washington DC.ORCID 0009-0009-7241-6033
Melinda C PowerDepartment of Epidemiology, Milken Institute School of Public Health, George Washington University, Washington DC.ORCID 0000-0001-9099-7964
Francine GrodsteinRush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL.ORCID 0000-0002-2699-7051
Alifiya KapasiRush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL.ORCID 0000-0003-1911-8482
Ana W CapuanoDepartment of Neurology, The University of Chicago, IL.ORCID 0000-0002-3505-344X
Brittney S Lange-MaiaRush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL.ORCID 0000-0001-6642-7558
Ali MoghtaderiDepartment of Health Policy and Management, George Washington University, Chicago, IL.ORCID 0000-0002-1728-6434
Emma K StappDepartment of Epidemiology, Milken Institute School of Public Health, George Washington University, Washington DC.ORCID 0000-0003-0628-0704
Joya BhattacharyyaDepartment of Epidemiology, Milken Institute School of Public Health, George Washington University, Washington DC.ORCID 0009-0008-9898-6408
Raj C ShahRush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL.ORCID 0000-0001-9706-9730
Lisa L BarnesRush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL.ORCID 0000-0002-0072-9817
David A BennettRush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL.ORCID 0000-0003-3689-554X
Bryan David JamesRush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL.ORCID 0000-0003-1932-151X

Funding

SUPPLEMENT TO RUSH ALZHEIMERS DISEASE CENTER COREP30AG010161 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 1991 to 2020
$49.1M
EPIDEMIOLOGY OF NEURAL RESERVE AND NEUROBIOLOGY IN AGINGR01AG017917 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 2001 to 2023
$43.3M
Rush Alzheimer's Disease Research CenterP30AG072975 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI Lisa L Barnes, Julie A. Schneider · 2021 to 2026
$24.7M
RISK FACTORS, PATHOLOGY, AND CLINICAL EXPRESSIONS OF ADR01AG015819 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 1998 to 2024
$21.4M
Risk Factors for Cognitive Decline in African-AmericansR01AG022018 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BARNES, LISA L · 2004 to 2025
$18.2M
Use of Healthcare Across the Full Continuum of Cognitive Health and Decline in Older AdultsR01AG079226 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI Julie PW Bynum, FRANCINE GRODSTEIN · 2022 to 2026
$3.1M
Predictors and consequences of the timing and accuracy of clinical dementia diagnosisR01AG072559 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI Bryan David James · 2022 to 2026
$2.9M
NIA NIH HHS P30 AG010161NIA NIH HHS P30 AG072975NIA NIH HHS R01 AG015819NIA NIH HHS R01 AG017917NIA NIH HHS R01 AG022018NIA NIH HHS R01 AG072559NIA NIH HHS R01 AG079226
6 · The paper itself

Abstract

BACKGROUND AND

objectivesA timely diagnosis of dementia may provide valuable time for treatment and planning, yet underdiagnosis is common. This study investigated the relationship between presence of dementia pathologies and timeliness of dementia diagnosis by healthcare providers.

methodsThis was a retrospective study using 5 cohorts at Rush Alzheimer's Disease Center. We included participants who met all of the following criteria: (1) incident dementia based on annual cohort assessments, (2) linkage to Medicare records, and (3) a completed postmortem brain autopsy. Postmortem neuropathologic examinations identified the presence of AD, limbic-predominant age-related TDP-43 encephalopathy neuropathologic change (LATE-NC), vascular pathologies, and neocortical Lewy bodies (LBs). In linked Medicare data, we defined timely diagnosis as the presence of claims with dementia diagnoses within 3 years before or 1 year after the cohort-based dementia onset. We used logistic regressions to quantify associations of neuropathology markers with timely diagnosis vs underdiagnosis.

resultsOf the 500 eligible participants (71% female, 95% non-Latino White, mean [SD] age at cohort dementia onset = 88 [7] years, mean [SD] years from onset to death = 4 [3]), only 54% received a timely diagnosis. After controlling for demographics, time to death, and other neuropathologies, a pathologic diagnosis of AD (OR = 1.91, 95% CI 1.21-3.00) and moderate/severe LATE-NC pathologies (OR = 1.83, 95% CI 1.25-2.68) were independently associated with higher odds of timely diagnosis. Moderate/severe vascular pathologies (OR = 0.94, 95% CI 0.55-1.59) and neocortical LB pathologies (OR = 1.00, 95% CI 0.64-1.55) were not significantly associated with receipt of a timely diagnosis. In a separate multivariable logistic regression, we found that participants with 3 or 4 neuropathologies present had an over 2-fold increase in odds of timely diagnosis (OR = 2.24, 95% CI 1.32-3.82), compared with those with 1 or no neuropathology. DISCUSSION: In deceased older adults with cohort-determined incident dementia, the healthcare system was twice as likely to capture those with pathologic diagnosis of AD, moderate/severe LATE-NC, and more than 3 copathologies in a timely manner. While findings from this predominantly White and highly educated sample warrant replication in broader population, this study is an important initial step toward understanding biological correlates of timely diagnosis of dementia.

Indexed as

Alzheimer DiseaseBrainDementiaAgedAged, 80 and overCohort StudiesFemaleHumansMaleMedicareRetrospective StudiesUnited States

Identifiers

PMID42485607
PMCPMC13445491

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.